tiprankstipranks
Trending News
More News >
Solvonis Therapeutics plc (GB:SVNS)
:SVNS
UK Market

Solvonis Therapeutics (SVNS) Income Statement

Compare
10 Followers

Solvonis Therapeutics Income Statement

Last quarter (Q4 2024), Solvonis Therapeutics's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Solvonis Therapeutics's net income was £-335.00K. See Solvonis Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 587.00K£ 542.00K£ 219.00K£ 690.86K£ 330.00K
Gross Profit
£ -134.00K£ -51.00K£ 55.00K£ 517.72K£ 284.00K
Operating Expenses
£ 3.26M£ 2.66M£ 900.00K£ 629.14K£ 748.00K
Depreciation and Amortization
£ 177.00K£ 113.00K£ 46.00K£ 121.71K£ 114.00K
EBITDA
£ -2.94M£ -2.59M£ -900.00K£ -322.29K£ -352.00K
Operating Income
£ -3.12M£ -2.71M£ -845.00K£ -111.43K£ -352.00K
Other Income/Expenses
£ -3.00K£ -4.00K£ -109.00K£ -162.86K£ -72.00K
Pretax Income
£ -3.12M£ -2.71M£ -954.00K£ -274.29K£ -538.00K
Net Income
£ -3.12M£ -2.71M£ -954.00K£ -274.29K£ -538.00K
Per Share Metrics
Basic EPS
£ -0.03£ -0.03£ -0.01£ 0.00£ -0.01
Diluted EPS
£ -0.03£ -0.03£ -0.01£ 0.00£ -0.01
Weighted Average Shares Outstanding
104.06M 103.59M 104.10M 104.10M 104.10M
Weighted Average Shares Outstanding (Diluted)
104.06M 103.59M 104.10M 104.10M 104.10M
Currency in GBP

Solvonis Therapeutics Earnings and Revenue History